CLDX (Celldex Therapeutics) Short-Term Debt to Capital
Celldex Therapeutics (CLDX) develops antibodies for the therapy of skin and autoimmune pathologies, leveraging partner support and interim test successes to attract investment. This chart reflecting the dynamics of the debt-to-equity ratio captured a value of 0.01, linking financial stability to the prospect of mass insurance reimbursements for drugs following the completion of clinical stages and regulatory approval.
Analytical breakdowns for Celldex Therapeutics
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital Celldex Therapeutics|CLDX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Celldex Therapeutics, Inc.|CLDX - Aggregate Debt Obligations|Debts to Book Capitalization Celldex Therapeutics Inc|CLDX - Long-Term Debt Volume|Company Short-Term Debt Celldex Therapeutics|Quick Liquidity celldex.com
- company profitability and valuation multiples indicators:
Fundamental valuation:Celldex
Investors assess liquidity risk via the ratio of short-term liabilities to equity to eliminate the threat of a cash gap. The implementation of robotic antibody screening systems at Celldex Therapeutics (CLDX) requires capital expenditures; therefore, the current short-term debt-to-equity chart allows for tracking the balance between external borrowings and business autonomy, where a decreasing ratio confirms financial stability while maintaining automation rates.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital auriniapharma.com|Short-Term Debt to Equity Ratio BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital DNTH (Dianthus Pharma)|Short-Term Debt to Capital Coefficient Pharvaris Pharma (PHVS)|ABCL - Short-Term Debt to Equity|tourmalinebio.com (TRML) - Short-Term Debt to Equity Ratio|Precigen (PGEN) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Pharming Group NV|Short-Term Debt to Equity Ratio NKTR|Short-Term Debt to Capital Upstream Pharma|Short-Term Debt to Equity Zenas Biopharma Inc (ZBIO)|immunome.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Current Liabilities to Capital|Septerna Corp - Short-Term Debt to Capital|Pieris Corp (PVLA) - Short-Term Debt to Equity Ratio|SVRA: Short-Term Debt to Capital|Current Liabilities to Capital rigel.com (RIGL)|Short-Term Debt to Equity AnaptysBio|Short-Term Debt to Equity ATXS|Short-Term Debt to Equity enGene Bio (ENGN)|Short-Term Debt to Equity RAPT (rapt.com)|Short-Term Debt to Capital JBIO (Aerovate Therapeutics)|ACRS: Short-Term Debt to Capital Ratio|Kyverna Therapeutics, Inc. - Short-Term Debt to Capital|Current Liabilities to Capital Tiziana Life Sciences Ltd.|CABA (Cabaletta Bio, Inc) - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Ratio VTYX|Short-Term Debt to Equity Ratio THTX|AVTX: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio ELDN (Eledon Pharmaceuticals, Inc.)|Short-Term Loans to Capital Ratio AGEN|Short-Term Debt to Capital CLYM (Climb Bio, Inc.)|Ratio of Short-Term Indebtedness to Capital ZURA|aTyr Pharma, Inc. - Short-Term Debt to Capital|Current Liabilities to Capital Adagene|ikenaoncology.com (IMA) - Short-Term Debt to Equity|Shattuck Labs - Ratio of Short-Term Indebtedness to Capital|EQ (Equillium Inc) - Short-Term Debt to Capital|Short-Term Debt to Capital Connect Pharma|Short-Term Debt to Equity Immunic, Inc. (IMUX)|ATRA: Current Liabilities to Equity|Short-Term Debt to Capital IFRX (InflaRx)|X4 Pharmaceuticals Inc. (XFOR) - Current Liabilities to Capital|ACET: Short-Term Debt to Equity Ratio|CELU - Short-Term Debt to Capital|INMB (INmune Bio, Inc.) - Short-Term Debt to Equity Ratio|BRNS: Short-Term Loans to Capital Ratio|KZR (Kezar Life Sciences, Inc.) - Short-Term Debt to Capital|SAB Biotherapeutics Inc. (SABS) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital AKTX|Short-Term Debt to Equity Ratio enlivex.com ENLV|Short-Term Debt to Equity Q32 Bio QTTB|Short-Term Debt to Capital Coefficient geovax.com (GOVX)|Edesa Biotech - Short-Term Debt to Capital|iBio Inc (IBIO) - Short-Term Debt to Equity Ratio|carismatx.com (CARM) - Short-Term Debt to Equity|XTLB (XTL Bio) - Short-Term Debt to Equity|BOLT (Bolt Biotherapeutics Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital Ratio HCWB (HCW Biologics Inc)|Short-Term Debt to Equity Ratio APVO (Aptevo Therapeutics)|aimimmuno.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Equity Aditxt, Inc. ADTX|GRI (GRI Bio Corporation) - Current Liabilities to Equity|XORTX Therapeutics Inc. - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital HIND (reshapelifesciences.com)|REVB: Short-Term Debt to Capital|Indaptus Therapeutics Inc (INDP) - Short-Term Debt to Capital|Short-Term Debt to Equity Scinai|CALI: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Affimed (AFMD)|Short-Term Debt to Equity Ratio allakos.com ALLK|Short-Term Debt to Capital HOOK (HOOKIPA Pharma)|Short-Term Debt to Capital IGM Biosciences Inc. IGMS|ITOS: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital OCEA (Ocean Biomedical Corp)|TCBP: Short-Term Debt to Capital|THRD - Short-Term Debt to Capital Coefficient